Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”

Tomonori Yamanishi, Tomohiko Kamasasko, Kanya Kaga, Miki Fuse